Report Thumbnail
Product Code DM0912414527Q7
Published Date 2026/5/7
English193 PagesGlobal

Infertility Treatment Market - 2026-2033 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code DM0912414527Q7◆An updated version may be available. We will check for you.
Published Date 2026/5/7
English 193 PagesGlobal

Infertility Treatment Market - 2026-2033 ‐ MedicalDevice / MedTech Market



Abstract

This comprehensive report provides an in-depth analysis of the global infertility treatment market, tracking its significant expansion through 2033. The study examines diverse segments, including assisted reproductive technologies, artificial insemination, and fertility surgeries, while categorizing products by equipment, media, and consumables. By evaluating key drivers and competitive dynamics across various patient types and end-users, the research offers actionable intelligence on technological trends and regional growth opportunities to support strategic decision-making in this evolving healthcare sector.

Related Questions

USD 3,222.8 million in 2025

8.10% (2026-2033)


Summary

Market Size and Growth

The Infertility Treatment Market reached USD 3,222.8 million in 2025 and is expected to reach USD 6,009.58 million by 2033, growing at a CAGR of 8.10% during the forecast period 2026-2033.

Executive Overview

The Infertility Treatment Market emerges as a key focus in DataM Intelligence's latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Infertility Treatment Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

Market Segmentation

By Procedure

  • Assisted Reproductive Technology*
  • In Vitro Fertilization
  • Intracytoplasmic Morphologically Selected Sperm Injection
  • Gamete Donation
  • Intracytoplasmic Sperm Injection
  • Surrogacy
  • Artificial Insemination*
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
  • Fertility Surgeries*
  • Laparoscopy
  • Hysteroscopy
  • Myomectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Varicocelectomy
  • Microsurgical Reconstruction:
  • Vasovasostomy
  • Vasoepididymostomy
  • Other Infertility Treatment Procedures

By Product

  • Equipment*
  • Microscopes
  • Imaging Systems
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • Media & Consumables
  • Accessories

By Patient Type

  • Female Infertility Treatment*
  • Male Infertility Treatment

By End-User

  • Fertility Centers*
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: U.K., Italy, Germany, Russia, France, Spain, The Netherlands, and Rest of Europe
  • Asia-Pacific: India, Japan, China, South Korea, Australia, Indonesia, and Rest of Asia Pacific
  • South America: Colombia, Brazil, Argentina, and Rest of South America
  • Middle East & Africa: Saudi Arabia, U.A.E., South Africa, and Rest of Middle East & Africa

Report Scope and Coverage

This report provides comprehensive analysis including:

  • Go-to-market Strategy.
  • A neutral perspective on market performance.
  • Development trends, competitive landscape analysis, supply side analysis, and demand side analysis.
  • Year-on-year growth, competitive benchmarking, and vendor identification.
  • Development status and other significant analysis.
  • Customized regional/country reports as per request and country level analysis.
  • Identification of potential and niche segments and regions exhibiting promising growth.
  • Detailed analysis of:
  • Market Size (historical and forecast)
  • Total Addressable Market (TAM)
  • Serviceable Available Market (SAM)
  • Serviceable Obtainable Market (SOM)
  • Market Growth
  • Technological Trends
  • Market Share
  • Market Dynamics
  • Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer)

Research Process

Both primary and secondary data sources have been used in the global Infertility Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including:

  • Governmental regulations
  • Market conditions
  • Competitive levels
  • Historical data
  • Market situation
  • Technological advancements
  • Upcoming developments in related businesses
  • Market volatility
  • Prospects, potential barriers, and challenges

Table of Contents

  • 1 Methodology and Scope

    • 1.1 Research Methodology
    • 1.2 Research Objective and Scope of the Report
  • 2 Market Definition and Overview

  • 3 Executive Summary

    • 3.1 Market Snippet by Product
    • 3.2 Market Snippet by Procedure
    • 3.3 Market Snippet by Patient Type
    • 3.4 Market Snippet by End-User
    • 3.5 Market Snippet by Region
  • 4 Market Dynamics

    • 4.1 Market Impacting Factors
      • 4.1.1 Drivers
        • 4.1.1.1 Declining fertility rate
      • 4.1.2 Restraints:
        • 4.1.2.1 High costs associated with assisted reproductive technology
      • 4.1.3 Opportunity
      • 4.1.4 Impact Analysis
  • 5 Industry Analysis

    • 5.1 Porter's Five Forces Analysis
    • 5.2 Supply Chain Analysis
    • 5.3 PEST Analysis
    • 5.4 Pricing Analysis
    • 5.5 Regulatory Analysis
    • 5.6 Unmet Needs
    • 5.7 Patent Analysis
  • 6 By Procedure

    • 6.1 Introduction
      • 6.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
      • 6.1.2 Market Attractiveness Index, By Procedure
    • 6.2 Assisted Reproductive Technology*
      • 6.2.1 Introduction
      • 6.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
      • 6.2.3 In Vitro Fertilization
      • 6.2.4 Intracytoplasmic Morphologically Selected Sperm Injection
      • 6.2.5 Gamete Donation
      • 6.2.6 Intracytoplasmic Sperm Injection
      • 6.2.7 Surrogacy
    • 6.3 Artificial Insemination
      • 6.3.1 Intrauterine Insemination
      • 6.3.2 Intracervical Insemination
      • 6.3.3 Intratubal Insemination
    • 6.4 Fertility Surgeries
      • 6.4.1 Laparoscopy
      • 6.4.2 Hysteroscopy
      • 6.4.3 Myomectomy
      • 6.4.4 Laparotomy
      • 6.4.5 Tubal Ligation Reversal
      • 6.4.6 Varicocelectomy
      • 6.4.7 Microsurgical Reconstruction
        • 6.4.7.1 Vasovasostomy
        • 6.4.7.2 Vasoepididymostomy
    • 6.5 Other Infertility Treatment Procedures
  • 7 By Product

    • 7.1 Introduction
      • 7.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      • 7.1.2 Market Attractiveness Index, By Product
    • 7.2 Equipment*
      • 7.2.1 Introduction
      • 7.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
      • 7.2.3 Microscopes
      • 7.2.4 Imaging Systems
      • 7.2.5 Sperm Analyzer Systems
      • 7.2.6 Ovum Aspiration Pumps
      • 7.2.7 Micromanipulator Systems
      • 7.2.8 Incubators
      • 7.2.9 Gas Analyzers
      • 7.2.10 Laser Systems
      • 7.2.11 Cryosystems
      • 7.2.12 Sperm Separation Devices
    • 7.3 Media & Consumables
    • 7.4 Accessories
  • 8 By Patient Type

    • 8.1 Introduction
      • 8.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
      • 8.1.2 Market Attractiveness Index, By Patient Type
    • 8.2 Female Infertility Treatment*
      • 8.2.1 Introduction
      • 8.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 8.3 Male Infertility Treatment
  • 9 By End-User

    • 9.1 Introduction
      • 9.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
      • 9.1.2 Market Attractiveness Index, By End-User Segment
    • 9.2 Fertility Centers*
      • 9.2.1 Introduction
      • 9.2.2 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 9.3 Hospitals & Surgical Clinics
    • 9.4 Cryobanks
    • 9.5 Research Institutes
  • 10 By Region

    • 10.1 Introduction
      • 10.1.1 Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      • 10.1.2 Market Attractiveness Index, By Region
    • 10.2 North America
      • 10.2.1 Introduction
      • 10.2.2 Key Region-Specific Dynamics
      • 10.2.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
      • 10.2.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      • 10.2.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
      • 10.2.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 10.2.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        • 10.2.7.1 U.S
        • 10.2.7.2 Canada
        • 10.2.7.3 Mexico
    • 10.3 Europe
      • 10.3.1 Introduction
      • 10.3.2 Key Region-Specific Dynamics
      • 10.3.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
      • 10.3.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      • 10.3.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
      • 10.3.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 10.3.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        • 10.3.7.1 Germany
        • 10.3.7.2 U.K
        • 10.3.7.3 France
        • 10.3.7.4 Italy
        • 10.3.7.5 Spain
        • 10.3.7.6 Rest of Europe
    • 10.4 South America
      • 10.4.1 Introduction
      • 10.4.2 Key Region-Specific Dynamics
      • 10.4.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
      • 10.4.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      • 10.4.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
      • 10.4.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 10.4.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        • 10.4.7.1 Brazil
        • 10.4.7.2 Argentina
        • 10.4.7.3 Rest of South America
    • 10.5 Asia Pacific
      • 10.5.1 Introduction
      • 10.5.2 Key Region-Specific Dynamics
      • 10.5.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
      • 10.5.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      • 10.5.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
      • 10.5.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 10.5.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        • 10.5.7.1 China
        • 10.5.7.2 India
        • 10.5.7.3 Japan
        • 10.5.7.4 Australia
        • 10.5.7.5 Rest of Asia Pacific
    • 10.6 Middle East and Africa
      • 10.6.1 Introduction
      • 10.6.2 Key Region-Specific Dynamics
      • 10.6.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
      • 10.6.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      • 10.6.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Patient Type
      • 10.6.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 11 Competitive Landscape

    • 11.1 Competitive Scenario
    • 11.2 Key Developments and Strategies
    • 11.3 Company Share Analysis
    • 11.4 Product Benchmarking
    • 11.5 Key Companies to Watch
    • 11.6 Company with disruptive technology
  • 12 Global Infertility Treatments Market- Company Profiles

    • 12.1 CooperSurgical Inc*
      • 12.1.1 Company Overview
      • 12.1.2 Product Portfolio and Description
      • 12.1.3 Key Highlights
      • 12.1.4 Financial Overview
    • 12.2 Vitrolife
    • 12.3 FUJIFILM Irvine Scientific, Inc
    • 12.4 Genea Limited
    • 12.5 IVFtech ApS
    • 12.6 Kitazato Corporation
    • 12.7 Rocket Medical plc
    • 12.8 Gynemedia
    • 12.9 Boston IVF
    • 12.10 Aspire Fertility(*LIST NOT EXHAUSTIVE)
  • 13 DataM Intelligence

    • 13.1 Appendix
    • 13.2 About Us and Services
    • 13.3 Contact Us
USD 4,800 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.